Results: Plasma levels of apelin and TNFα were higher in obese compared with lean controls.
Introduction
Apelin has been described as a new adipokine, produced and secreted by human and mouse mature adipocytes (1) . Apelin is a bioactive peptide identified as the endogenous ligand of APJ, a G protein-coupled receptor (2, 3) . Apelin peptides are derived from a 77-amino-acid precursor, which is processed to several active molecular forms such as apelin-36 or apelin-13 in different tissues and in the bloodstream (4) . Apelin and APJ have been found to be expressed in the hypothalamus, stomach, endothelial cells, vascular smooth muscle cells, cardiomyocytes (for review see 5) , in mouse adipocytes (6) and human osteoblasts (7) .
The most documented functions of apelin/APJ concern the regulation of fluid homeostasis (8) and the modifications of cardiac contractility and blood pressure (5) .
So far, few data regarding the regulation of apelin or APJ are available, specially in humans. Apelin and APJ expression have been shown to follow a same pattern of regulation in human heart failure (9) . Regulation of apelin expression by insulin (1) and by TNFα (10) in human adipocytes or adipose tissue (AT) has also been reported. Moreover the basal plasma levels of apelin are significantly higher in obese patients compared to control lean individuals (1) , correlating positively with BMI (11) . These data suggest that apelin could play an important role in obesity-related metabolic and cardiovascular alterations.
Therefore, the aim of this study was 1) to investigate whether the increased plasma apelin levels previously reported in obese subjects are reduced after a hypocaloric diet in obese women and 2) to study the effect of the hypocaloric diet on the expression of apelin and APJ in human subcutaneous abdominal AT. 
Subjects and Methods

Subjects
Twenty obese women (age: 39.4 ± 9.5 years, range of body weight 72. 5 
Examination procedures
The subjects were investigated at 8 a.m. after an overnight fast before and at the end of 12 weeks of low-calorie diet (LCD). The clinical parameters of the subjects are shown in Table 1 . Body composition was assessed using multifrequency bioimpedance (Bodystat, Quad scan 4000, Isle of Man). Coefficients of variation of fat mass, fat free mas and impedance were respectively 1.7%, 0.8% and 1.5% respectively. Samples of 10 ml of blood were from carbohydrate. Subjects were given oral and written instructions relating to these targets based on either a template or an exchange system. Subjects were requested to abstain from alcohol consumption. The dietary instructions were reinforced and monitored by dieticians weekly. Compliance to the diet was monitored using one-day-weighed food records that were presented each week during the above mentioned dietary consultation. session. In addition to that, a 3-day-weighed food record of two weekdays and one weekend day was performed before the study and during the last week of the intervention. The dietary records were analyzed using the food-nutrient database routinely used in each center.
Real-time RT-PCR
Total RNAs (0.5 µg) were isolated from AT biopsies using RNeasy Lipid Tissue Kits (QIAGEN, France) and were reverse transcribed using random hexamers and Superscript II reverse transcriptase (Invitrogen, UK). Real time PCR was generated by SYBER green method and performed as previously described (1). Analysis of the 18 S ribosomal RNA was performed in parallel using the ribosomal RNA control Taqman Assay Kit (Applied Biosystem) to normalize gene expression. The following oligonucleotide primers pairs were used: apelin Sens : GCGGTTATGTCTCCTCCATAGATT Reverse :
GTGCGAGGTGAGAGCTGAATG; APJ Sens : GCCCTTGCTTTCTGAAAATCA Reverse :
GGACAGTTAAAGGATGTGCATAGGA.
Analytical methods
Plasma glucose was determined by the glucose-oxidase technique (Beckman Instruments, CA). Plasma insulin concentration was measured by RIA (Immunotech, Czech Republic). 6 Plasma apelin levels were measured with a commercially available enzyme-linked immunoassay (ELISA) kit (Phoenix Pharm., USA). The sensitivity of the assay was 0.2 ng/ml and the intraassay error was below 5%. The ELISA had 100% cross-reactivity with human apelin-12, apelin13 and apelin-36. Concentrations of TNFα in plasma were measured using ultra-sensitive ELISA kit (Biosource International, USA).
Statistical analysis
Statistical analysis was performed using SPSS 12.0 for Windows (SPSS Inc., USA).
Differences were tested with nonparametric Wilcoxon's test for paired observations.
Correlations were analysed by Spearman's nonparametric test. Data are presented as means ± SEM. Differences at the level of P < 0.05 were considered statistically significant. 
Results
Effect of LCD on metabolic variables
The LCD resulted in mean body weight loss of 6.7 ± 0.6 kg (7.4% loss of the initial body weight), a reduction of total and HDL cholesterol, plasma triglycerides and no change in blood glucose and blood pressure. Moreover, homeostasis model assessment index of insulin resistance (HOMA-IR) was decreased suggesting an increase in insulin sensitivity of the subjects (table 1) .
Effect of LCD on plasma apelin, insulin and TNFα levels
Apelin plasma levels were elevated in obese (369 ± 25 pg/ml, n=20) compared to lean women (272 ± 20 pg/ml, n = 12, P = 0.02). After LCD, plasma levels of apelin in obese subjects were significantly decreased (figure 1). Plasma concentrations of TNFα (0.66 ± 0.04 pg/ml, n=20 vs 0.54 ± 0.07 pg/ml, n=12, P = 0.014 ) and insulin (8.16 ± 0.73 mU/ml, n=20 vs 4.31± 0.56 mU/ml, n=12) were also higher in obese compared to controls and, like apelin, decreased after LCD (figure 1).
Associations of plasma apelin levels with anthropometric and metabolic variables
No correlation between the diet-induced decrease of insulin or TNFα blood levels and plasma apelin was found in the entire group. Then the patients were stratified into two subgroups according to the magnitude of the diet-induced decrease of insulin resistance: group 1 (designated as high-responders, n = 12) with a decrease of HOMA-IR by more than 20% of the initial value; group 2 (low-responders, n = 8) with a decrease of HOMA-IR ≤ 20%. In the subgroup of high-responders, the diet-induced changes in plasma apelin levels directly correlated with the diet-induced decrease of metabolic variables such as plasma insulin and TNFα levels ( Table 2 ) but also the decrease of HOMA-IR , waist circumference
and Waist-to-hip ratio (WRH).
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Effect of LCD on apelin and APJ expression in adipose tissue
In order to know whether the observed decrease of apelin plasma levels could be due to reduced production of apelin by AT, apelin mRNA level was measured in lean and obese subjects before and after LCD. Apelin mRNAs were increased in obese compared to lean subjects ( figure 2A ) and a significant diet-induced decrease of apelin mRNA was observed after LCD. Thus, apelin plasma levels and apelin expression in AT were decreased in obese subjects after LCD ( figure 3 ). Since apelin and APJ expression have been shown to often follow a same regulation pattern (9), we studied the expression of APJ in AT in lean and obese subjects before and after LCD. Interestingly, the expression of apelin receptor APJ was also significantly increased in obese compared to lean subjects and decreased in AT after LCD ( figure 2B ). Moreover, a tight positive correlation was observed between changes in apelin and changes in APJ mRNA levels (figure 4). 
Discussion
Elevated plasma apelin has been described by our group in moderately (1) and by
Heinonen et al in severe obese (11) . It has also been shown that plasma apelin levels were increased in diabetic subjects and positively correlated with BMI, HOMA-IR and fasting plasma insulin (12) , suggesting a role of apelin in the pathogenesis of type II diabetes.
However, no data are available on a potential reversal of the elevated plasma apelin in obese subjects. In the present study, the hypocaloric diet associated with weight reduction resulted in a reduction of plasma apelin levels. At the end of the diet, the plasma apelin levels in obese approached the range found in lean controls. The diet-induced reduction of plasma apelin was assoaciated with a decrease of apelin mRNA expression in subcutaneous adipose tissue. It is to be noted that the diet-induced changes described in this study may be due to body weight loss ( i.e. reduction to body fat mass) as well as to the effect of the caloric restriction, i.e.
negative energy balance, itself.
It is interesting to note that the relationship between apelin and insulin or TNFα during obesity and obesity-associated disorders (1, 10, 12) is still maintained maintained at the end of the hypocaloric diet but is dependent of the magnitude of insulin sensitivity.
Therefore, insulin and TNFα, could be potential candidates involved in the regulation of the diet-induced decrease of apelin blood levels, in agreement with previous studies (1, 6, 10).
Leptin could be another candidate regulating apelin production. Indeed, a high correlation has been described between apelin gene expression in subcutaneous AT and leptin serum or leptin mRNA in rat AT (13) . In addition, since a correlation between apelin and HOMA-IR was observed only in subjects ameliorating their insulin sensitivity, the relationship between apelin and insulin resistance is strengthened. The relationship of apelin to blood pressure changes was not assessed since in spite of diet-induced apelin decrease, no correlation between the individual diet-induced change of plasma apelin and systolic and diastolic blood In addition to the effect of the hypocaloric diet on apelin, we also studied APJ expression in AT. Apelin and APJ receptor are often co-localized in the same tissues and display similar variations of expression. The most documented co-regulation of the apelin/APJ system was reported in the cardiovascular domain. Either down-regulated (9) or increased expression (14) of both apelin and APJ were observed in humans or rodents heart presenting cardiac dysfunction. In the current study, we found not only a decrease of APJ and apelin expression after LCD period but also a significant correlation between the diet-induced changes of apelin and APJ expression in AT. Therefore, a similar regulation of apelin and APJ mRNA expression in human AT may be suggested and a common factor regulating apelin and APJ expression could be hypothesized.
In conclusion, the present study demonstrates that, in obese women, the hypocaloric diet associated with weight reduction and with a decrease of insulin resistance promotes a reduction of the elevated plasma apelin levels and of the expression of apelin and APJ in subcutaneous AT. Although apelin has been viewed as a beneficial adipokine up-regulated in obesity (15, 16) , it remains to establish whether the increased levels of apelin observed in obesity are an attempt to overcome either insulin resistance or obesity-related cardiovascular 
